申请人:Pfizer Inc.
公开号:US05362743A1
公开(公告)日:1994-11-08
Certain novel 3-acyl-4-amino-8-alkoxyquinoline compounds have been prepared, including their pharmaceutically-acceptable salts. These compounds are useful for inhibiting gastric acid secretion in mammals and therefore, are of value in therapy as anti-ulcer agents. They are also useful for treating osteoporosis in a mammalian subject afflicted with said condition. Methods for preparing these compounds from known starting materials are provided.
已经合成了某些新型的3-酰基-4-氨基-8-烷氧基喹啉化合物,包括它们的药学上可接受的盐。这些化合物对于抑制哺乳动物的胃酸分泌很有用,因此在治疗抗溃疡剂方面具有价值。它们还可用于治疗患有骨质疏松症的哺乳动物。提供了从已知起始材料制备这些化合物的方法。